|Description||ACHP, an IkB kinase inhibitor, has been found to exhibit activities in inducing apoptosis in human myeloma cell lines.|
|Purity||≥97% by HPLC|
BI605906 is a novel pharmacological inhibitors of the IKK family. It inhibits IKKβ with an IC50 value of 380 nM when assayed at 0.1 mM ATP in vitro. It also inh...
TPCA-1 is an inhibitor of IKK-2 with IC50 of 17.9 nM, inhibits NF-κB pathway, exhibits 22-fold selectivity over IKK-1.
IKK-3 Inhibitor is a potent, selective, inhibitor of IKK-epsilon kinase and is inactive at IKK-α and IKK-β.
Amlexanox is a specific inhibitor of IKKε and TBK1, which inhibits IKKε and TBK1 activity as determined by MBP phosphorylation.
Bay 65-1942 free base
Bay 65-1942 is an ATP-competitive inhibitor that selectively targets IKKβ kinase.
BX795 is a potent and selective inhibitor of PDK1, IKKε and TBK1, which regulates the production of Type 1 interferons during bacterial and viral infection. BX7...
MRT67307 is a potent and dual IKKϵ and TBK1 inhibitor with IC50 of 160 and 19 nM, respectively. It is an inhibitor for ULK1and ULK2 with IC50 value of 45 and 38...
Bay 65-1942 hydrochloride
Bay 65-1942 hydrochloride is an ATP-competitive inhibitor that selectively targets IKKβ kinase.